Related Experiment Video
Updated: Sep 5, 2025

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
Published on: April 26, 2016
Chitosan-modified nanocarriers as carriers for anticancer drug delivery: Promises and hurdles
Fahad Saad Alhodieb1, Md Abul Barkat2, Harshita Abul Barkat3
1Department of Clinical Nutrition, College of Applied Health Sciences in Arrass, Qassim University, P.O. BOX:6666, Buraidah, 51452, Saudi Arabia.
Abstract:
With the advent of drug delivery, various polymeric materials are being explored to fabricate numerous nanocarriers. Each polymer is associated with a few characteristics attributes which further facilitate its usage in drug delivery. One such polymer is chitosan (CS), which is extensively employed to deliver a variety of drugs to various targets, especially to cancer cells. The desired properties like biological origin, bio-adhesive, biocompatibility, the scope of chemical modification, biodegradability and controlled drug release make it a highly rough after polymer in pharmaceutical nanotechnology. The present review attempts to compile various chemical modifications on CS and showcase the outcomes of the derived nanocarriers, especially in cancer chemotherapy and drug delivery.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...

